Skip to content

Dr. E. MULLIEZ

Active
Private limited companyfounded 200620 yrs activeRijselstraat 88, 8900 Ieper, BelgiumKBO/BCE: BE 0880.650.726
Summary

Dr. E. MULLIEZ has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €3.2m and a net result of €386,245. Equity remains stable across the filed fiscal years (±1.8% per year). Its solvency ranks better than 71% of 186 sector peers (fiscal year 2026). The computed 12-month bankruptcy probability is < 0.1% (very low).

Risk analysisWatch ReportCompare
Dr. E. MULLIEZActiveChecked score 94/100
Risk analysis ReportCompare

Overview

Activity
Specialist medical practice
NACE 86220
#9 company by equity in Ypres, Health and social work sector1 site
Size
€3.6mtotal assets 2026
Equity
€3.2m
Profit
€386,245
Turnover not published (abridged schema)
Financial health
94 Excellent Checked score 2026
Bankruptcy chance 12 m
< 0.1%
Structure
Accounts 2 d early0 of 3 deeds read
Why 94+ Size: total assets €3.6m+ Figures for FY 2026 (filed 28-09-2026)+ Sector Human health activities (NACE 86)+ Equity €3.2m (88.5% of total assets)Show the evidence

Checked score

Score 2026
94 / 100
Excellent
Probability in this band: under 0.55%
Better than 51% of its sector peers (NACE 86, small)
Performance against the sector, not lower risk
Every signal that weighs is under Signals.
Financial strength · tick = 2025
Strong
Solvency 100=
equity 88.5% of total assets
Liquidity 58+2
short-term debt 3.8% · cash 6.2%
Profitability 82+1
return on assets 10.7%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,070 companies)
Last 24 months 11-2024: < 0.1%lowest value 12-2024: < 0.1%● 0.0% vs 11-2024lowest value 01-2025: < 0.1%● 0.0% vs 12-2024lowest value 02-2025: < 0.1%● 0.0% vs 01-2025lowest value 03-2025: < 0.1%● 0.0% vs 02-2025lowest value 04-2025: < 0.1%▲ +5.0% vs 03-2025 05-2025: < 0.1%▲ +9.5% vs 04-2025 06-2025: < 0.1%▲ +8.7% vs 05-2025 07-2025: < 0.1%▲ +4.0% vs 06-2025 08-2025: < 0.1%▲ +19.2% vs 07-2025 09-2025: < 0.1%▲ +25.8% vs 08-2025 10-2025: 0.1%▲ +35.9% vs 09-2025highest value 11-2025: < 0.1%▼ -60.4% vs 10-2025 12-2025: < 0.1%● 0.0% vs 11-2025 01-2026: < 0.1%● 0.0% vs 12-2025 02-2026: < 0.1%● 0.0% vs 01-2026 03-2026: < 0.1%● 0.0% vs 02-2026 04-2026: < 0.1%● 0.0% vs 03-2026 05-2026: < 0.1%▲ +14.3% vs 04-2026 06-2026: < 0.1%▲ +4.2% vs 05-2026 07-2026: < 0.1%▲ +4.0% vs 06-2026 08-2026: < 0.1%▲ +19.2% vs 07-2026 09-2026: < 0.1%▲ +25.8% vs 08-2026 10-2026: < 0.1%▼ -46.2% vs 09-2026
  • Size: total assets €3.6m lowers the probability for this profile
  • Figures for FY 2026 (filed 28-09-2026) lowers the probability
  • Sector Human health activities (NACE 86) lowers the probability
  • Equity €3.2m (88.5% of total assets) lowers the probability
Credit up to €300,000 at 30 days acceptable
Liquidity ample (current ratio 17.83 against 17.62 in 2025; short-term debt: 3.8% and cash: 6.2% of total assets), and 11.5% of the assets are financed with debt.
How it is calculated

The band comes from the bankruptcy probability on a scale of 0 to 100: every 10 points more double the odds of getting through the year without bankruptcy.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Place inside the band: half the bankruptcy probability, half how the company does against its sector peers (NACE 86, small). Better than this share of them on solvency 77%, liquidity 41%, profitability 54%, growth against the median 34%. That is performance, not lower risk; the band itself always comes from the probability.

Bankruptcy probability: model pd-v3.202610021621, computed on 03-10-2026. The model learns from Belgian bankruptcies and reads the registers, the annual accounts and the gazette.

Ceilings: negative or zero equity, a heavy loss, a special KBO legal situation and a missing filing 59 (two missing 44), an ongoing judicial reorganisation or an ending 24. Financial strength does not count in the score.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Six signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Size: total assets €3.6m
In the bankruptcy model this factor lowers the probability for this profile.
NBB · annual accounts
lowers risk · Figures for FY 2026 (filed 28-09-2026)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Sector Human health activities (NACE 86)
In the bankruptcy model this factor lowers the probability.
KBO
lowers risk · Equity €3.2m (88.5% of total assets)
In the bankruptcy model this factor lowers the probability.
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2024 and did not fall compared with 2025. These amounts do not establish the cause of the change.
NBB · annual accounts 2026
Equity per financial year
1920212223242526
2019 to 2026 · latest year €3.2m
neutral · Latest accounts filed on time
The financial year that closed on 28-02-2026 was due by 30-09-2026 and was filed on 28-09-2026, 2 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2026
2 d early
2025
1 d early
2024
7 d late
2023
2 d late
2022
6 d late
2021
28 d late
2020
22 d late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 9 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 28-02-2027 and is due by 30-09-2027. Nothing is late today. Usually files around 2 October (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Position in the running window
04-10-2026 today28-02-2027 close30-09-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage
  1. Annual accounts filedfiscal year 2026 · micro…
  2. Annual accounts filedfiscal year 2025 · micro…
  3. Annual accounts filedfiscal year 2024 · micro…

Key points

  • Positive: Among the best 5% on net resultsector median €60,503 · 189 companies €386,245 View
  • Positive: 8 profitable years in a rowprofit 2026: €386,245 8 years View
  • Total assets 20266 fiscal years filed €3.6m View

By topic

Financials

Fiscal year
2026
Total assets
€3.6m
Profit
€386,245
Solvency
88.5%
Total assets▼ 0.5%
Net result
20192026
Go to Financials

Timeline

Events
12
Since
2017
Next accounts
by 30-09-2027
  1. 28-09-2026Annual accounts filed
  2. 29-09-2025Annual accounts filed
  3. 07-10-2024Annual accounts filed
Go to Timeline

Company details

Sites
1
Legal form
Private limited company
Activity
Specialist medical practiceNACE 86220
Founded
11-04-2006
Year ends
28-02
Peppol
Not found in the Peppol directory
Go to Company details

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure